Liothyronine sodium 5 ug/1
Liothyronine sodium · TABLET · Zydus Pharmaceuticals (USA) Inc.
No Recall History
Plain English
Liothyronine sodium is a tablet containing liothyronine sodium at 5 ug/1, taken oral. Manufactured by Zydus Pharmaceuticals (USA) Inc..
Key Facts
- Brand Name
- Liothyronine sodium
- Generic Name
- Liothyronine sodium
- NDC Code (Product)
68382-582- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Strength
- 5 ug/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA214803
- Marketing Start
- 02/01/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
headache491 reports
drug ineffective444 reports
hypertension352 reports
dyspnoea323 reports
hypothyroidism318 reports
asthma306 reports
therapeutic product effect incomplete296 reports
gastrooesophageal reflux disease292 reports
fatigue288 reports
burning sensation286 reports
Frequently Asked Questions
What is Liothyronine sodium used for?
Liothyronine sodium contains Liothyronine sodium. It is a tablet taken oral. Consult your doctor for specific uses.
Is Liothyronine sodium a controlled substance?
Liothyronine sodium is not classified as a controlled substance by the DEA.
What is the generic name for Liothyronine sodium?
The generic name for Liothyronine sodium is Liothyronine sodium. There are 8 other brand versions of Liothyronine sodium.
What is the NDC code for Liothyronine sodium 5 ug/1?
The NDC (National Drug Code) for Liothyronine sodium 5 ug/1 is 68382-582, listed by Zydus Pharmaceuticals (USA) Inc..